跳至主要内容
临床试验/NCT02885805
NCT02885805已完成不适用

Sun Protection Factor (SPF) Efficacy Assay

Bayer0 个研究点目标入组 11 人开始时间: 2015年6月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Bayer
入组人数
11
主要终点
Sun Protection Factor (SPF) efficacy on the skin of human subjects before a total of 2 hours of water Immersion

研究概览

简要总结

Evaluation of the effectiveness of a sunscreen product by determining its Sun Protection Factor (SPF) on the skin of human subjects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Fitzpatrick Skin Type I, II and/or 111 for UVB testing; Fitzpatrick Skin Type II, 111 and/or IV for UVA testing.
  • Sex: Male or female.
  • Age: 18-70 years.
  • Good health as determined from the HRL SHF.
  • Signed and dated lnformed Consent Form.
  • Signed and dated HIPAA Form.
  • An unambiguous MED or MPPD

排除标准

  • 未提供

研究组 & 干预措施

SPF evaluation + Control

Experimental

Fair-skinned subjects in good health with Skin Types I, II or III.

干预措施: BAY987516 (Drug)

SPF evaluation + Control

Experimental

Fair-skinned subjects in good health with Skin Types I, II or III.

干预措施: SPF 15 Control (Drug)

结局指标

主要结局

Sun Protection Factor (SPF) efficacy on the skin of human subjects before a total of 2 hours of water Immersion

时间窗: up to 24 hours post-exposure

The subsites on each of the protected test sites \[test sunscreen and/or Control\] shall be exposed to UV light. The value of each subsite exposure shall be as appropriate to the test Method: the subject's Minimal Erythema Dose (MED) or MPPD Minimal Persistent Pigment Darkening Dose (MPPD) multiplied by the specific time intervals required. The unprotected skin site is divided into five subsites and shall also be exposed to UV light. The time intervals selected are a geometric series represented by (1.25)n, (n = the subjects MED or MPPD, at the middle \[3"'\] subsite) wherein each exposure time interval is 25 percent greater than the previous time or intensity. The SPF of each TM for each subject is then calculated from the exposure time interval required to produce the MED or MPPD of the protected skin, and from the exposure time interval required to produce the MED or MPPD of the unprotected skin.

Sun Protection Factor (SPF) efficacy on the skin of human subjects after a total of 2 hours of water Immersion

时间窗: up to 24 hours post-exposure

The subsites on each of the protected test sites \[test sunscreen and/or Control\] shall be exposed to UV light. The value of each subsite exposure shall be as appropriate to the test Method: the subject's Minimal Erythema Dose (MED) or MPPD Minimal Persistent Pigment Darkening Dose (MPPD) multiplied by the specific time intervals required. The unprotected skin site is divided into five subsites and shall also be exposed to UV light. The time intervals selected are a geometric series represented by (1.25)n, (n = the subjects MED or MPPD, at the middle \[3"'\] subsite) wherein each exposure time interval is 25 percent greater than the previous time or intensity. The SPF of each TM for each subject is then calculated from the exposure time interval required to produce the MED or MPPD of the protected skin, and from the exposure time interval required to produce the MED or MPPD of the unprotected skin.

次要结局

未报告次要终点

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

相似试验

Sun Protection Factor (SPF) Efficacy Assay | 临床试验